Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The negative association between gout and rheumatoid arthritis is widely accepted, and gout is also speculated to be rare in
systemic lupus erythematosus
(
SLE
), as only a few sporadic cases have been reported. From 1985 to 2001 we encountered 15
lupus
patients at Chang-Gung Memorial Hospital, including two with
lupus
-scleroderma and one with
lupus
-scleroderma-polymyositis overlap syndrome coexisting with gout. This study retrospectively analyses the clinical and laboratory characteristics of these patients. A lower female predominance is found, and most patients developed gout after the onset of
SLE
, although gout preceded
SLE
in two cases. Measurement of serum uric acid and 24-h urine uric acid found all of the patients to be hyperuricaemic and underexcretors of uric acid. Furthermore, most of the patients (14/15) were receiving diuretics. Also, many had hypertension and serious cardiovascular diseases. Renal impairment during gouty attacks seemed to be a predisposing factor for developing end-stage renal disease. Gouty arthritis usually occurred during relative
SLE
inactivity,
podagra
was frequent, and tophi were found in a few patients. Compared with the unselected population of
SLE
patients, the cases studied here had a higher incidence of chronic arthritis, malar rash, haematologic disorder, photosensitivity, serositis and neurologic disorder. Renal disease in the patients sampled was frequently membranous nephropathy.
...
PMID:Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study. 1457 59